Evolving from its niche status, vitamin K2 is entering mainstream markets and consumer channels.

As consumer awareness grows, so too does demand and the market is reaching a tipping point: what is the future for the K2 market and where is the opportunity for manufacturers investing in K2? Jorg Buttinghaus, VP Sales and Marketing at Kappa Bioscience, joins us once more for the third instalment in our series on vitamin K2 to discuss the future for this increasingly popular ingredient. We also cover the industry's requirement to educating consumers responsibly and accurately and call on stakeholders at all stages in the supply chain to combat misinformation.